Valuation: AcouSort AB

Market Cap 67.51M 6.85M 6.13M 5.66M 5.12M 9.58M 652M 9.73M 26.93M 341M 25.7M 25.15M 1.08B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 67.51M 6.85M 6.13M 5.66M 5.12M 9.58M 652M 9.73M 26.93M 341M 25.7M 25.15M 1.08B EV / Sales 2026 *
6.82x
EV / Sales 2027 * 4.56x
Free-Float
70.68%
Yield 2026 *
-
Yield 2027 * -
1 day-5.34%
1 week-6.18%
Current month+27.60%
1 month+12.72%
3 months-10.14%
6 months-18.83%
Current year+12.72%
1 week 3.03
Extreme 3.03
3.49
1 month 2.37
Extreme 2.37
3.99
Current year 2.03
Extreme 2.03
5.16
1 year 2.03
Extreme 2.03
5.16
3 years 2.03
Extreme 2.03
24
5 years 2.03
Extreme 2.03
32.95
10 years 2.03
Extreme 2.03
32.95
Manager TitleAgeSince
Chief Executive Officer 68 2013-12-31
Director of Finance/CFO 65 2015-12-31
Director TitleAgeSince
Chairman 62 2025-12-31
Director/Board Member - 2021-11-30
Director/Board Member 60 2025-06-24
Change 5-day change 1-year change 3-year change Capi.($)
-5.34%-6.18%+9.62%-85.16% 7.19M
+0.34%-3.03%+37.45%+61.06% 64.14B
+0.98%+2.26%+12.91%+82.98% 55.53B
+1.75%+2.76%+12.38%+103.69% 53.03B
-1.43%-1.17%+26.27%+55.26% 45.99B
-0.48%-2.80%+18.01%+99.11% 42.45B
+0.82%+1.37%+227.94%+936.89% 40.45B
-0.26%-4.20%+10.86%+45.18% 32.25B
-2.07%+44.58%+102.84%+88.74% 34.47B
-2.72%-8.79%+22.58%-5.63% 24.23B
Average -0.87%+3.35%+48.09%+138.21% 39.25B
Weighted average by Cap. -0.11%+3.13%+49.45%+160.61%

Financials

2026 *2027 *
Net sales 9.9M 1M 899K 830K 751K 1.4M 95.63M 1.43M 3.95M 50.05M 3.77M 3.69M 159M 14.8M 1.5M 1.34M 1.24M 1.12M 2.1M 143M 2.13M 5.9M 74.82M 5.63M 5.51M 237M
Net income - -
Net Debt - -
Projected Income Statement - Annual - AcouSort AB
Logo AcouSort AB
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Employees
11
Date Price Change Volume
26-10-29 SEK 3.190 -5.34% 21,133
26-10-28 SEK 3.370 +3.37% 1,440
26-10-27 SEK 3.260 -1.51% 27,442
26-10-26 SEK 3.310 -1.49% 27,094
26-10-23 SEK 3.360 -2.61% 32,428

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AcouSort AB
  1. Stock Market
  2. Stocks
  3. ACOU Stock